310 related articles for article (PubMed ID: 18021871)
1. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study.
Vaccarino V; Johnson BD; Sheps DS; Reis SE; Kelsey SF; Bittner V; Rutledge T; Shaw LJ; Sopko G; Bairey Merz CN;
J Am Coll Cardiol; 2007 Nov; 50(21):2044-50. PubMed ID: 18021871
[TBL] [Abstract][Full Text] [Related]
2. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).
Johnson BD; Kip KE; Marroquin OC; Ridker PM; Kelsey SF; Shaw LJ; Pepine CJ; Sharaf B; Bairey Merz CN; Sopko G; Olson MB; Reis SE;
Circulation; 2004 Feb; 109(6):726-32. PubMed ID: 14970107
[TBL] [Abstract][Full Text] [Related]
3. Depression, the metabolic syndrome and cardiovascular risk.
Vaccarino V; McClure C; Johnson BD; Sheps DS; Bittner V; Rutledge T; Shaw LJ; Sopko G; Olson MB; Krantz DS; Parashar S; Marroquin OC; Merz CN
Psychosom Med; 2008 Jan; 70(1):40-8. PubMed ID: 18158378
[TBL] [Abstract][Full Text] [Related]
4. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study.
Rutledge T; Reis SE; Olson MB; Owens J; Kelsey SF; Pepine CJ; Mankad S; Rogers WJ; Merz CN; Sopko G; Cornell CE; Sharaf B; Matthews KA; Vaccarino V
Arch Gen Psychiatry; 2006 Aug; 63(8):874-80. PubMed ID: 16894063
[TBL] [Abstract][Full Text] [Related]
5. Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.
Kip KE; Marroquin OC; Shaw LJ; Arant CB; Wessel TR; Olson MB; Johnson BD; Mulukutla S; Sopko G; Merz CN; Reis SE
Am Heart J; 2005 Nov; 150(5):900-6. PubMed ID: 16290958
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study.
Tuomisto K; Jousilahti P; Sundvall J; Pajunen P; Salomaa V
Thromb Haemost; 2006 Mar; 95(3):511-8. PubMed ID: 16525580
[TBL] [Abstract][Full Text] [Related]
7. Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
Linke SE; Rutledge T; Johnson BD; Vaccarino V; Bittner V; Cornell CE; Eteiba W; Sheps DS; Krantz DS; Parashar S; Bairey Merz CN
Arch Gen Psychiatry; 2009 May; 66(5):499-507. PubMed ID: 19414709
[TBL] [Abstract][Full Text] [Related]
8. The role of inflammatory markers in explaining the association between depression and cardiovascular hospitalisations.
Hiles SA; Baker AL; de Malmanche T; McEvoy M; Boyle M; Attia J
J Behav Med; 2015 Aug; 38(4):609-19. PubMed ID: 25835436
[TBL] [Abstract][Full Text] [Related]
9. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.
Kip KE; Marroquin OC; Kelley DE; Johnson BD; Kelsey SF; Shaw LJ; Rogers WJ; Reis SE
Circulation; 2004 Feb; 109(6):706-13. PubMed ID: 14970104
[TBL] [Abstract][Full Text] [Related]
10. Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study.
Rutledge T; Linke SE; Krantz DS; Johnson BD; Bittner V; Eastwood JA; Eteiba W; Pepine CJ; Vaccarino V; Francis J; Vido DA; Merz CN
Psychosom Med; 2009 Nov; 71(9):958-64. PubMed ID: 19834049
[TBL] [Abstract][Full Text] [Related]
11. Depression, C-reactive protein and two-year major adverse cardiac events in men after acute coronary syndromes.
Frasure-Smith N; Lespérance F; Irwin MR; Sauvé C; Lespérance J; Théroux P
Biol Psychiatry; 2007 Aug; 62(4):302-8. PubMed ID: 17210140
[TBL] [Abstract][Full Text] [Related]
12. Hostility scores are associated with increased risk of cardiovascular events in women undergoing coronary angiography: a report from the NHLBI-Sponsored WISE Study.
Olson MB; Krantz DS; Kelsey SF; Pepine CJ; Sopko G; Handberg E; Rogers WJ; Gierach GL; McClure CK; Merz CN;
Psychosom Med; 2005; 67(4):546-52. PubMed ID: 16046366
[TBL] [Abstract][Full Text] [Related]
13. Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease.
Rallidis LS; Varounis C; Sourides V; Charalampopoulos A; Kotakos C; Liakos G; Dagres N; Apostolou T; Anastasiou-Nana M
Curr Med Res Opin; 2011 Jul; 27(7):1407-13. PubMed ID: 21568834
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation.
Marroquin OC; Kip KE; Kelley DE; Johnson BD; Shaw LJ; Bairey Merz CN; Sharaf BL; Pepine CJ; Sopko G; Reis SE;
Circulation; 2004 Feb; 109(6):714-21. PubMed ID: 14970105
[TBL] [Abstract][Full Text] [Related]
15. A prospective evaluation of the directionality of the depression-inflammation relationship.
Stewart JC; Rand KL; Muldoon MF; Kamarck TW
Brain Behav Immun; 2009 Oct; 23(7):936-44. PubMed ID: 19416750
[TBL] [Abstract][Full Text] [Related]
16. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women.
Wessel TR; Arant CB; Olson MB; Johnson BD; Reis SE; Sharaf BL; Shaw LJ; Handberg E; Sopko G; Kelsey SF; Pepine CJ; Merz NB
JAMA; 2004 Sep; 292(10):1179-87. PubMed ID: 15353530
[TBL] [Abstract][Full Text] [Related]
17. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome.
Sukhija R; Fahdi I; Garza L; Fink L; Scott M; Aude W; Pacheco R; Bursac Z; Grant A; Mehta JL
Am J Cardiol; 2007 Apr; 99(7):879-84. PubMed ID: 17398176
[TBL] [Abstract][Full Text] [Related]
19. DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Shufelt C; Bretsky P; Almeida CM; Johnson BD; Shaw LJ; Azziz R; Braunstein GD; Pepine CJ; Bittner V; Vido DA; Stanczyk FZ; Bairey Merz CN
J Clin Endocrinol Metab; 2010 Nov; 95(11):4985-92. PubMed ID: 20739385
[TBL] [Abstract][Full Text] [Related]
20. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study.
Arant CB; Wessel TR; Olson MB; Bairey Merz CN; Sopko G; Rogers WJ; Sharaf BL; Reis SE; Smith KM; Johnson BD; Handberg E; Mankad S; Pepine CJ;
J Am Coll Cardiol; 2004 Jun; 43(11):2009-14. PubMed ID: 15172405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
